Colonic Diseases  >>  etrolizumab (RG7413)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
etrolizumab (RG7413) / Roche
EUCALYPTUS, NCT01336465 / 2011-000897-80: Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Checkmark UEGW 2014: Ulcerative colitis(EUCALYPTUS )
Oct 2014 - Oct 2014: UEGW 2014: Ulcerative colitis(EUCALYPTUS )
Checkmark ulcerative colitis
May 2014 - May 2014: ulcerative colitis
Checkmark DDW 2014: ulcerative colitis
More
Completed
2
124
US, Canada, Europe, RoW
placebo, rhuMAb Beta7
Genentech, Inc.
Ulcerative Colitis
09/12
06/13

Download Options